Cargando…

Ascertainment rate of novel coronavirus disease (COVID-19) in Japan

OBJECTIVE: To estimate the ascertainment rate of novel coronavirus disease (COVID-19). METHODS: The epidemiological dataset of confirmed cases with COVID-19 in Japan as of February 28, 2020 was analyzed. A statistical model was constructed to describe the heterogeneity of the reporting rate by age a...

Descripción completa

Detalles Bibliográficos
Autores principales: Omori, Ryosuke, Mizumoto, Kenji, Nishiura, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206424/
https://www.ncbi.nlm.nih.gov/pubmed/32389846
http://dx.doi.org/10.1016/j.ijid.2020.04.080
_version_ 1783530414104641536
author Omori, Ryosuke
Mizumoto, Kenji
Nishiura, Hiroshi
author_facet Omori, Ryosuke
Mizumoto, Kenji
Nishiura, Hiroshi
author_sort Omori, Ryosuke
collection PubMed
description OBJECTIVE: To estimate the ascertainment rate of novel coronavirus disease (COVID-19). METHODS: The epidemiological dataset of confirmed cases with COVID-19 in Japan as of February 28, 2020 was analyzed. A statistical model was constructed to describe the heterogeneity of the reporting rate by age and severity. We estimated the number of severe and non-severe cases, accounting for under-ascertainment. RESULTS: The ascertainment rate of non-severe cases was estimated at 0.44 (95% confidence interval 0.37–0.50), indicating that the unbiased number of non-severe cases would be more than twice the reported count. CONCLUSIONS: Severe cases are twice as likely to be diagnosed and reported when compared to other cases. Considering that reported cases are usually dominated by non-severe cases, the adjusted total number of cases is also approximately double the observed count. This finding is critical in interpreting the reported data, and it is advised that the mild case data for COVID-19 should always be interpreted as under-ascertained [Au?1].
format Online
Article
Text
id pubmed-7206424
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-72064242020-05-08 Ascertainment rate of novel coronavirus disease (COVID-19) in Japan Omori, Ryosuke Mizumoto, Kenji Nishiura, Hiroshi Int J Infect Dis Article OBJECTIVE: To estimate the ascertainment rate of novel coronavirus disease (COVID-19). METHODS: The epidemiological dataset of confirmed cases with COVID-19 in Japan as of February 28, 2020 was analyzed. A statistical model was constructed to describe the heterogeneity of the reporting rate by age and severity. We estimated the number of severe and non-severe cases, accounting for under-ascertainment. RESULTS: The ascertainment rate of non-severe cases was estimated at 0.44 (95% confidence interval 0.37–0.50), indicating that the unbiased number of non-severe cases would be more than twice the reported count. CONCLUSIONS: Severe cases are twice as likely to be diagnosed and reported when compared to other cases. Considering that reported cases are usually dominated by non-severe cases, the adjusted total number of cases is also approximately double the observed count. This finding is critical in interpreting the reported data, and it is advised that the mild case data for COVID-19 should always be interpreted as under-ascertained [Au?1]. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020-07 2020-05-08 /pmc/articles/PMC7206424/ /pubmed/32389846 http://dx.doi.org/10.1016/j.ijid.2020.04.080 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Omori, Ryosuke
Mizumoto, Kenji
Nishiura, Hiroshi
Ascertainment rate of novel coronavirus disease (COVID-19) in Japan
title Ascertainment rate of novel coronavirus disease (COVID-19) in Japan
title_full Ascertainment rate of novel coronavirus disease (COVID-19) in Japan
title_fullStr Ascertainment rate of novel coronavirus disease (COVID-19) in Japan
title_full_unstemmed Ascertainment rate of novel coronavirus disease (COVID-19) in Japan
title_short Ascertainment rate of novel coronavirus disease (COVID-19) in Japan
title_sort ascertainment rate of novel coronavirus disease (covid-19) in japan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206424/
https://www.ncbi.nlm.nih.gov/pubmed/32389846
http://dx.doi.org/10.1016/j.ijid.2020.04.080
work_keys_str_mv AT omoriryosuke ascertainmentrateofnovelcoronavirusdiseasecovid19injapan
AT mizumotokenji ascertainmentrateofnovelcoronavirusdiseasecovid19injapan
AT nishiurahiroshi ascertainmentrateofnovelcoronavirusdiseasecovid19injapan